Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumorsChengwen Zhang, Ingrid Herr, Till Wenger et al.|Cancer Biology & Therapy|2007Cited by 102
The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Roland Penzel, C. Kortsik et al.|Lung Cancer|2012Cited by 13
KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the LiteratureSandra Gottschling, Thomas Kuhnt, Roland Penzel et al.|Journal of Clinical Oncology|2011Cited by 6